Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.
PURPOSE OF REVIEW Improved survival in primary CNS lymphoma (PCNSL) has increased the importance of delayed treatment-related neurotoxicity as a determinant of functional outcome and quality of life. This review summarizes contemporary evidence on neurocognitive outcomes across modern therapies and discusses the challe...